Compagnie Lombard Odier S Cm A Abb Vie Inc. Transaction History

Compagnie Lombard Odier S Cm A

$5.66 Billion
Q2 2024

A detailed history of Compagnie Lombard Odier S Cm A transactions in Abb Vie Inc. stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 328,710 shares of ABBV stock, worth $64 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

328,710

Previous 334,224 1.65%

Holding current value

$64 Million

Previous $60.9 Million 7.36%

% of portfolio

1.0%

Previous 1.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$154.79 - $180.76 $853,512 - $996,710	-5,514 Reduced 1.65%	328,710 $56.4 Million
Q1 2024 May 01, 2024	BUY	$159.82 - $182.1 $538,113 - $613,130	3,367 Added 1.02%	334,224 $60.9 Million
Q4 2023 Jan 16, 2024	BUY	$137.6 - $154.97 $3.22 Million - $3.63 Million	23,408 Added 7.61%	330,857 $51.3 Million
Q3 2023 Oct 23, 2023	SELL	$133.59 - $154.65 $1.02 Million - $1.18 Million	-7,655 Reduced 2.43%	307,449 $45.8 Million
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $4.84 Million - $6.02 Million	-36,492 Reduced 10.38%	315,104 $42.5 Million
Q1 2023 May 01, 2023	SELL	$144.61 - $166.54 $9.84 Million - $11.3 Million	-68,023 Reduced 16.21%	351,596 $56 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $1.45 Million - $1.74 Million	-10,473 Reduced 2.44%	419,619 $67.8 Million
Q3 2022 Nov 09, 2022	SELL	$134.21 - $153.93 $5.53 Million - $6.35 Million	-41,232 Reduced 8.75%	430,092 $57.7 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $3.09 Million - $3.92 Million	-22,428 Reduced 4.54%	471,324 $72.2 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $8.58 Million - $10.6 Million	-65,024 Reduced 11.64%	493,752 $80 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $7.24 Million - $9.17 Million	-67,437 Reduced 10.77%	558,776 $75.7 Million
Q3 2021 Oct 28, 2021	SELL	$106.4 - $120.78 $47.6 Million - $54 Million	-447,080 Reduced 41.65%	626,213 $67.6 Million
Q2 2021 Jul 15, 2021	BUY	$105.21 - $117.21 $85,535 - $95,291	813 Added 0.08%	1,073,293 $121 Million
Q1 2021 Apr 23, 2021	SELL	$102.3 - $112.62 $12.1 Million - $13.3 Million	-118,304 Reduced 9.93%	1,072,480 $116 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $6.22 Million - $8.39 Million	-77,235 Reduced 6.09%	1,190,784 $128 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $1.32 Million - $1.54 Million	15,319 Added 1.22%	1,268,019 $111 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $9.66 Million - $12.9 Million	131,721 Added 11.75%	1,252,700 $123 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $2.53 Million - $3.83 Million	-39,159 Reduced 3.38%	1,120,979 $85.4 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $2.71 Million - $3.39 Million	-37,549 Reduced 3.14%	1,160,138 $103 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $15 Million - $18.1 Million	-238,874 Reduced 16.63%	1,197,687 $90.7 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $16.4 Million - $21 Million	249,688 Added 21.04%	1,436,561 $104 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $1.53 Million - $1.8 Million	19,801 Added 1.7%	1,186,873 $95.6 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $10.3 Million - $12.7 Million	-132,291 Reduced 10.18%	1,167,072 $108 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $1.73 Million - $1.92 Million	-19,436 Reduced 1.47%	1,299,363 $123 Million
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $889,989 - $1.05 Million	9,913 Added 0.76%	1,318,799 $122 Million
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $14.9 Million - $20 Million	-162,331 Reduced 11.03%	1,308,886 $124 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $16.2 Million - $17.8 Million	-181,384 Reduced 10.98%	1,471,217 $142 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $19.4 Million - $24.8 Million	-278,256 Reduced 14.41%	1,652,601 $147 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,930,857	1,930,857 $140 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.

Account

Compagnie Lombard Odier S Cm A Abb Vie Inc. Transaction History